Recent developments in the management of idiopathic cholestatic liver disease.
In recent years, the clinical management of patients with idiopathic cholestatic liver disease has shown significant progress. Advancement of diagnostic and therapeutic approaches and better understanding of the pathophysiology underlying these diseases have all contributed considerably to this progress. In this review, we aim to touch briefly on several developments that have occurred in this regard and to discuss novel findings and interventions valuable to clinical practice.
Division of Gastroenterology and Hepatology; Mayo Clinic Rochester, Minnesota, USA.
Mohamad H
MH
Imam
Division of Gastroenterology and Hepatology; Mayo Clinic Rochester, Minnesota, USA.
Emma
E
Weeding
Division of Gastroenterology and Hepatology; Mayo Clinic Rochester, Minnesota, USA.
Keith D
KD
Lindor
corticosteroids; management; primary biliary cirrhosis; primary sclerosing cholangitis; ursodeoxycholic acid